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important pathways in the process and contribute 
to attenuated response of newborn PMN to LPS in 
vitro. 
12 
Infection and Distribution Patterns of Beta and 
Gamma Herpesviruses in Waldeyer's Ring Tissue 
C. Berger*, M. Hug, D. Nadat. Division o[In[ectious 
Diseases, University Children's Hospital of Zurich, 
8032 ZUrich, Switzerland 
Background: The Lymphoid tissue of the orophar- 
ynx acts as a portal of entry and exit and as reser- 
voir for the human beta and gamma herpesviruses 
(HHV) foLLowing primary infection and estabLish- 
ment of Latency. 
Objective: To elucidate frequencies and quantities 
of the human beta HHV (HHV-5, -6, -7) and gamma 
HHV (HHV-4, -8) in adenoids and palatine tonsils. 
Methods: We determined the presence and the 
quantities of HHV-4, -5, -6, -7 and -8 in autoLogous 
adenoids and palatine tonsils from children under- 
going three-tonsiLLectomy for medical reasons using 
in-house established quantitative poLymerase chain 
reaction assays with Lower detection Limits ranging 
between 2 and 10 HHV DNA copies/~g DNA. 
Results: HHV-4 (Epstein-Barr virus) was detected 
in 80% of the organs from 30 children, HHV-5 (cy- 
tomegaLovirus) in 637o, and HHV-6 and HHV-7 in 77% 
each. HHV-8 was not detected. If detectable in a 
patient, HHV-4 was found in 73% in both adenoid 
and tonsils, HHV-5 in 237O, HHV-6 in 407O, and HHV-7 
in 53%. The number of DNA copies of a given HHV in 
autoLogous adenoids and tonsils significantly corre- 
Lated for HHV-4 and HHV-7 (p = 0.04 and p = 0.0007, 
respectively), but not for HHV-5 and HHV-6. The 
HHV DNA LeveLs correlated between HHV-5 and 
HHV-6 in adenoids and tonsils (p = 0.01 and p = 0.02, 
respectively) and between HHV-5 and HHV-7 in 
tonsils (p = 0.04), but not between other HHV. 
Conclusions: The different correlations of quanti- 
tative contents in autoLogous adenoids and tonsils 
suggest for HHV-5 and HHV-6 infection and distri- 
bution patterns distinct from those of HHV-4 and 
HHV-7. 
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Randomized Controlled Trial of Oral vs. 
Sequential Intravenous/Oral Cephalosporins 
in Dimercaptosuccinic Acid (DMSA) 
Scintigraphy-documented Acute Pyelonephritis 
in Children 
C. Berger, K. Buechner, E. Girardin*, U. WiLLi, 
T.J. Neuhaus, D. NadaL For the Swiss 
Pyelonephritis Study Group. Divisions of 
Infectious Diseases, University Children's Hospital 
of Zurich, Zurich, Switzerland 
Background: No study has assessed the efficacy and 
safety of oral antibiotics in children with DMSA- 
documented pyeLonephritis. 
Objectives: To compare efficacy and safety of oral 
versus sequential intravenous/oraL cephatosporin 
treatment of acute pyeLonephritis in children. 
Methods: 235 children aged 6 months to 16 years 
with a febrile urinary tract infection - rectal tem- 
perature >38 °, C-reactive protein (CRP) >10mg/t, 
and bacterial growth in cultures from urine coL- 
Lected by catheter - were prospectively randomly 
assigned to receive either intravenous ceftriaxone 
(50 mg/kg once daily) for 3 days, foLLowed by oral 
ceftibuten (9 mg/kg once daily) for 11 days or oral 
ceftibuten for 14 days. A first DMSA scintigraphy to 
detect acute renal Lesions was performed within 
5 days. Micturition cystogram and 2nd DMSA were 
performed after 6 weeks and 6 months, respec- 
tively. ExcLusion criteria were complex renal maL- 
formations and septicat appearance. 
Results: 150 children (64?o; 132 females (f) and 
18 males (m); median age 25 months, range 6-189) 
had acute renal Lesions on DMSA. 71 (47%; 61 f, 
10 m; median age 20 months) were given cetri- 
axone/ceftibuten, 79 (53%; 71 f, 8 m; median 
age 27 months) ceftibuten. One patient from the 
oral regimen only had to be switched to intra- 
venous therapy due to repeated vomiting. The 
2nd DMSA showed persistent Lesions (scars) in 
33 children (46?o; 29 f, 4 m) treated with ceftriax- 
one/ceftibuten versus 19 (24%; 18 f, 1 m) treated 
with ceftibuten (p = 0.004). 
Conclusions: In children with DMSA-documented 
pyeLonephritis, oral antibiotic therapy for 14 days 
with once daily ceftibuten is effective, safe 
and convenient, and resulted in significantly 
tess renal scars than sequential intravenous/oraL 
cephatosporin therapy. 
